Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.41 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11595983 | 0.97 | NFKB1 (0.55) | NFKB1ALOX15BLMSMN1; SMN2KDM4E | |
| SCHEMBL28802807 | 0.97 | NFKB1 (0.55) | NFKB1ALOX15BLMSMN1; SMN2KDM4E | |
| SCHEMBL17195442 | 0.87 | KDM4E (0.48) | NFKB1ALOX15BLMSMN1; SMN2KDM4E | |
| SCHEMBL9750144 | 0.85 | KDM4E (0.63) | NFKB1ALOX15BLMSMN1; SMN2KDM4E | |
| SCHEMBL5173538 | 0.83 | — | — | |
| SCHEMBL4729088 | 0.83 | — | — | |
| SCHEMBL20894303 | 0.83 | NFKB1 (0.43) | NFKB1ALOX15BLMSMN1; SMN2KDM4E | |
| SCHEMBL5171513 | 0.81 | — | — | |
| SCHEMBL10848882 | 0.81 | — | — | |
| SCHEMBL20929042 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115670-A1 | A METHOD FOR PREPARING SUPPORTED MOF MEMBRANES INDUCED BY LOW-CRYSTAL AGGREGATED STATE STRUCTURES, MOF MEMBRANES AND THEIR APPLICATIONS | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2026-04-30 | — | — | US | claimed |
| US-12576386-B2 | Aluminum-based metal-organic framework having three dimensional porous structure and comprising at least two types of ligands, preparation method therefor, and use thereof | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-03-17 | — | — | US | claimed |
| US-20250360468-A1 | SEPARATION MEMBRANE COMPLEX AND METHOD OF PRODUCING SEPARATION MEMBRANE COMPLEX | NGK INSULATORS, LTD. (JP) | 2025-11-27 | — | — | US | claimed |
| CN-115642364-B | High-adhesion lithium ion battery diaphragm and preparation method thereof | 江苏厚生新能源科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119350645-A | Preparation method and application of micron-sized GM-1 material | 南京师范大学 | 2025-01-24 | — | — | CN | claimed |
| CN-119221048-A | Anti-warping additive, electrolytic copper foil bath solution, copper foil, preparation method and application thereof | 吉和昌新材料(荆门)有限公司 | 2024-12-31 | — | — | CN | claimed |
| WO-2024190041-A1 | SEPARATION MEMBRANE COMPOSITE BODY AND METHOD FOR PRODUCING SEPARATION MEMBRANE COMPOSITE BODY | 日本碍子株式会社 | 2024-09-19 | — | — | WO | claimed |
| CN-118047816-A | Fluorine-containing iron-based metal organic framework material, preparation method and application | 中国科学院大连化学物理研究所 | 2024-05-17 | — | — | CN | claimed |
| CN-117700778-A | Preparation method of hydrophobic metal organic framework material particles | 中国辐射防护研究院 | 2024-03-15 | — | — | CN | claimed |
| CN-117701281-A | Metal-organic framework and fluoride nanocrystalline composite photon functional material and preparation method thereof | 浙江大学杭州国际科创中心 | 2024-03-15 | — | — | CN | claimed |
| CN-103073480-B | A kind of preparation method of the carboxylic acid of 2 penta [c] pyrroles of (tertbutyloxycarbonyl) octahydro ring 5 | 武汉药明康德新药开发有限公司 | 2017-08-29 | — | — | CN | claimed |
| US-9714320-B2 | Process for preparing a high molecular weight heteroaromatic polyester or copolyester | UHDE INVENTA-FISCHER GMBH (DE) | 2017-07-25 | — | — | US | claimed |
| EP-2814864-A2 | PROCESS FOR PREPARING A HIGH MOLECULAR WEIGHT HETEROAROMATIC POLYESTER OR COPOLYESTER | Uhde Inventa-Fischer GmbH (DE) | 2014-12-24 | — | — | EP | claimed |
| US-20140357808-A1 | Process For Preparing A High Molecular Weight Heteroaromatic Polyester Or Coplyester | UHDE INVENTA-FISCHER GMBH (DE) | 2014-12-04 | — | — | US | claimed |
| US-8653048-B2 | Prodrugs based on gemcitabine structure and synthetic methods and applications thereof | SANLUGEN PHARMATECH LTD. (CN) | 2014-02-18 | — | — | US | claimed |
| WO-2013120989-A2 | PROCESS FOR PREPARING A HIGH MOLECULAR WEIGHT HETEROAROMATIC POLYESTER OR COPOLYESTER | UHDE INVENTA-FISCHER GMBH (DE) | 2013-08-22 | — | — | WO | claimed |
| CN-102428093-A | Prodrugs based on gemcitabine structure as well as synthetic method and application thereof | SANLUGEN PHARMATECH LTD | 2012-04-25 | — | — | CN | claimed |
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | SANLUGEN PHARMATECH LTD. (CN) | 2012-04-12 | — | — | US | claimed |
| EP-2423215-A1 | PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF | Sanlugen Pharmatech Ltd. (CN) | 2012-02-29 | — | — | EP | claimed |
| US-5308861-A | Tetrapyrole compounds | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1994-05-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | TYMP, DCTD, GLS2 | NFKB1 2429/4885ALOX15 2359/4885BLM 918/4885 |
| US-12576386-B2 | Aluminum-based metal-organic framework having three dimensional porous structure and comprising at least two types of ligands, preparation method therefor, and use thereof | ALAD, SLC38A7, SLC5A11 | NFKB1 501/4885ALOX15 41/4885BLM 1484/4885 |
| US-20260115670-A1 | A METHOD FOR PREPARING SUPPORTED MOF MEMBRANES INDUCED BY LOW-CRYSTAL AGGREGATED STATE STRUCTURES, MOF MEMBRANES AND THEIR APPLICATIONS | AP2M1, PICALM, AP1M1 | NFKB1 1132/4885ALOX15 94/4885BLM 3534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.